ASCP Corner

Improving the Practice of Clinical Psychopharmacotherapy: The Process of Long-Term Management for Patients and Caregivers

June 24, 2015

Ira D. Glick, James M. Ellison

ASCP Corner

Bipolar Therapeutics Update 2014: A Tale of 3 Treatments

January 28, 2015

Terence A. Ketter, Shefali Miller, Po W. Wang

ASCP Corner

Updates and Trends in the Treatment of Major Depressive Disorder

December 24, 2014

George I. Papakostas, Dawn F. Ionescu

ASCP Corner

Can We Bottle Psychosocial Treatments for Addiction? The Role of Oxytocin

September 25, 2014

Christopher S. Stauffer, Joshua D. Woolley

ASCP Corner

Hoarding Disorder: More Than Just a Problem of Too Much Stuff

August 26, 2014

Carol A. Mathews

ASCP Corner

Whatever Happened to New Treatments for Alzheimer’s Disease?

July 25, 2014

Davangere P. Devanand

ASCP Corner

Inflammatory Depression: A Trifecta of Trouble

June 27, 2014

Charles L. Raison

ASCP Corner

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

March 15, 2014

Christoph U. Correll, Swapnil Gupta, John D. Cahill, et al

ASCP Corner

The ASCP Annual Meeting (NCDEU): A History

February 15, 2014

Maurizio Fava

ASCP Corner

The Role of Vitamin D in Depression: From a Curious Idea to a Therapeutic Option

November 15, 2013

Cédric Annweiler, Reza Rastmanesh, Stéphane Richard-Devantoy, et al

ASCP Corner

Decision Making and Antipsychotic Medication Treatment for Youth With Autism Spectrum Disorders: Applying Guidelines in the Real World

October 15, 2013

Christoph U. Correll, Stephanie H. Ameis, Patricia Corbett-Dick, et al

ASCP Corner

Antidepressant Use in Pregnancy and Risk of Autism Spectrum Disorders: A Critical Examination of the Evidence

September 15, 2013

Chittaranjan Andrade

ASCP Corner

Pulsed Intravenous Administration of Scopolamine Produces Rapid Antidepressant Effects and Modest Side Effects

August 15, 2013

Maura L. Furey

ASCP Corner

Autism Diagnosis Criteria Changes (DSM-5)

July 15, 2013

Read a full article on the major Autism Diagnosis Criteria Changes in the fifth edition of DSM-5.

Eric P. Hazen, Christopher J. McDougle, Fred R. Volkmar

ASCP Corner

Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder Comorbidity in Children and Adolescents: Evidence-Based Approach to Diagnosis and Treatment

June 15, 2013

Terence A. Ketter, Kiki D. Chang, Shefali Miller

ASCP Corner

Current Status of Ketamine and Related Compounds for Depression

May 15, 2013

Daniel C. Mathews

ASCP Corner

Lessons Learned From d-Cycloserine: The Promise and Limits of Drug Facilitation of Exposure Therapy

April 15, 2013

Thomas L. Rodebaugh, Eric J. Lenze

ASCP Corner

Reconsidering Chronic Hyponatremia in Psychosis

March 15, 2013

Richard C. Josiassen, Dawn M. Filmyer, Alexander G. Geboy, et al

ASCP Corner

Monoamine Oxidase Inhibitors Revisited: What You Should Know

February 15, 2013

Michael E. Thase, Joseph F. Goldberg

ASCP Corner

Cardiovascular Disease and Bipolar Disorder: Risk and Clinical Implications

December 15, 2012

Andrea Fagiolini, Holly A. Swartz

ASCP Corner

Discordance Between Researchers and Patients in Defining Remission From Depression

September 15, 2012

Mark Zimmerman

ASCP Corner

Stepping Back to Step Forward: Lessons From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

October 24, 2011

Andrew A. Nierenberg, Amy T. Peters

ASCP Corner

Assessing the Adequacy of Past Antidepressant Trials: A Clinician’s Guide to the Antidepressant Treatment Response Questionnaire

August 15, 2011

David Mischoulon, Maurizio Fava, Marlene P. Freeman, et al

ASCP Corner

Rediscovering Adverse Anticholinergic Effects

June 15, 2011

Bruce G. Pollock, Philip Gerretsen

ASCP Corner

ELSEWHERE:

FOLLOW US:

ASCP Corner

ASCP Corner Articles

Improving the Practice of Clinical Psychopharmacotherapy: The Process of Long-Term Management for Patients and Caregivers

Bipolar Therapeutics Update 2014: A Tale of 3 Treatments

Updates and Trends in the Treatment of Major Depressive Disorder

Can We Bottle Psychosocial Treatments for Addiction? The Role of Oxytocin

Hoarding Disorder: More Than Just a Problem of Too Much Stuff

Whatever Happened to New Treatments for Alzheimer’s Disease?

Inflammatory Depression: A Trifecta of Trouble

The Endocannabinoid System and Schizophrenia: Links to the Underlying Pathophysiology and to Novel Treatment Approaches

The ASCP Annual Meeting (NCDEU): A History

The Role of Vitamin D in Depression: From a Curious Idea to a Therapeutic Option

Decision Making and Antipsychotic Medication Treatment for Youth With Autism Spectrum Disorders: Applying Guidelines in the Real World

Antidepressant Use in Pregnancy and Risk of Autism Spectrum Disorders: A Critical Examination of the Evidence

Pulsed Intravenous Administration of Scopolamine Produces Rapid Antidepressant Effects and Modest Side Effects

Autism Diagnosis Criteria Changes (DSM-5)

Bipolar Disorder and Attention-Deficit/Hyperactivity Disorder Comorbidity in Children and Adolescents: Evidence-Based Approach to Diagnosis and Treatment

Current Status of Ketamine and Related Compounds for Depression

Lessons Learned From d-Cycloserine: The Promise and Limits of Drug Facilitation of Exposure Therapy

Reconsidering Chronic Hyponatremia in Psychosis

Monoamine Oxidase Inhibitors Revisited: What You Should Know

Cardiovascular Disease and Bipolar Disorder: Risk and Clinical Implications

Discordance Between Researchers and Patients in Defining Remission From Depression

Stepping Back to Step Forward: Lessons From the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Assessing the Adequacy of Past Antidepressant Trials: A Clinician’s Guide to the Antidepressant Treatment Response Questionnaire

Rediscovering Adverse Anticholinergic Effects

Learn More About Psychedelics in Psychiatry

Subscribe to readmore articles

Subscribe to read
more articles